Fadogia Agrestis

Fadogia agrestis
Evidence Level
Preliminary
4 Clinical Trials
3 Documented Benefits
1/5 Evidence Score

Fadogia agrestis (also classified as Vangueria agrestis) is an African shrub sold in supplements marketed for testosterone. It has not been tested in people. In male rats, 28 days of a stem extract altered testicular markers in ways the authors called adverse and raised serum enzymes and malondialdehyde that the authors linked to disrupted liver and kidney cell membranes. It is used in traditional African medicine as an aphrodisiac and for pain, fever and malaria. The research behind its testosterone reputation is a 5-day rat study in which the same extract, at the same doses, raised serum testosterone and mating behavior. No human trial was found in PubMed or ClinicalTrials.gov, so there is no tested human dose and no shown human benefit or safety record. In an analysis of 17 supplements claiming to contain fadogia, the plant's measured phenolic compounds were not detected in 5.

Studied Dose No human dose has been tested. Rat studies gave 18, 50 or 100 mg/kg a day of a water extract of the stem by mouth for 5 days (raised testosterone) or 28 days (adverse testicular, liver and kidney marker changes).
Active Compound Not established. Alkaloids and saponins detected, anthraquinones and flavonoids weakly present; monoterpene glycosides and phenolic compounds identified.

Benefits

Serum testosterone in male rats

In male rats, a water extract of fadogia stem given by mouth at 18, 50 or 100 mg/kg a day raised serum testosterone at every dose over 5 days, in a pattern the authors described as suggestive of dose dependence. This has not been tested in people, and 28 days at the same doses altered testicular markers in rats.

Mating behavior in male rats

In the same 5-day rat study, all three doses increased mount and intromission frequency, shortened the time to first mount and intromission, and prolonged ejaculation latency. Fadogia is used in traditional African medicine as an aphrodisiac, but no human study of libido or sexual function was found.

Traditional fever remedy screened in cell culture

Fadogia was one of seven plants chosen from a Burkina Faso survey of traditional medicine for a lab screen, where its alkaloid extract inhibited a chloroquine-resistant malaria parasite in culture (IC50 between 4 and 10 micrograms/mL). No human or animal study of this use was found; it is a historical-use note, not a health benefit.

Mechanism of action

1

Raised serum testosterone in rats

Over 5 days, 18, 50 and 100 mg/kg of the stem extract raised serum testosterone in male rats, which the authors proposed as the cause of the increased mating behavior. Whether this works through LH or directly on the testes was not studied, and 28 days at the same doses altered testicular function markers.

2

Constituents identified in the plant

Screening of the stem extract found alkaloids and saponins, with anthraquinones and flavonoids weakly present. Later work isolated six monoterpene glycosides and profiled 73 compounds, including phenolic acids, flavonoids and terpene glycosides. Which of these, if any, drive the rat findings is unknown.

3

Nitric oxide and cGMP markers in rat penile tissue

In male rats whose mating behavior had been lowered with paroxetine, 18, 50 and 100 mg/kg of the extract raised penile and testicular nitric oxide, cGMP and antioxidant enzymes and lowered PDE5, arginase and oxidative stress markers toward control levels. Groups had 5 rats each; no human data.

4

Same doses given for 28 days changed rat organ markers

The rat studies that found adverse testicular, liver and kidney marker changes used the same 18 to 100 mg/kg doses as the 5-day testosterone study, given for 28 days. Partial recovery after stopping was seen on some testicular indices, mainly at 18 mg/kg.

Clinical trials

1
Testosterone and mating behavior in male rats
PubMed

Animal study: water extract of Fadogia agrestis stem by mouth at 18, 50 or 100 mg/kg daily, with sexual behavior and serum testosterone measured on days 1, 3 and 5; no human participants (Yakubu et al. 2005, Asian J Androl)

Male albino rats.

All three doses increased mount and intromission frequency, shortened mount and intromission latency, prolonged ejaculatory latency and raised serum testosterone, in a pattern the authors described as suggestive of dose dependence. Screening of the extract found alkaloids and saponins, with anthraquinones and flavonoids weakly present.

2
Testicular function indices in male rats over 28 days
PubMed

Animal study: 18, 50 or 100 mg/kg of the stem extract by mouth daily for 28 days versus water, followed by a 10-day recovery period; biochemical measures only in the abstract (Yakubu et al. 2008, J Ethnopharmacol)

Male rats (Rattus norvegicus).

At all doses the extract raised the testes-to-body weight ratio, testicular cholesterol, sialic acid, glycogen and gamma-glutamyl transferase, and lowered alkaline phosphatase, glutamate dehydrogenase and protein; the abstract lists acid phosphatase among both the increases and the decreases. The authors read these as adverse effects on testicular function. Recovery on some indices was seen mainly at 18 mg/kg.

3
Liver and kidney markers in male rats over 28 days
PubMed

Animal study: 18, 50 or 100 mg/kg of the stem extract by mouth daily for 28 days versus water (Yakubu et al. 2009, Hum Exp Toxicol)

Male rats.

The extract lowered alkaline phosphatase, lactate dehydrogenase and gamma-glutamyl transferase in the liver and kidney with corresponding rises in serum, and raised serum malondialdehyde in all treated groups, which the authors read as disruption of liver and kidney cell membranes. No deaths, clinical toxicity signs or changes in liver or kidney weight ratios were seen.

4
Penile and testicular markers in paroxetine-treated rats
PubMed

Animal study: 30 male Wistar rats in 6 groups of 5; paroxetine was used to lower mating behavior, then rats received the stem extract at 18, 50 or 100 mg/kg; the authors say clinical trials are needed before human use (Ogunro et al. 2023, Reprod Sci)

Male Wistar rats.

The extract raised penile and testicular nitric oxide, cGMP, catalase, superoxide dismutase, glutathione and related thiol markers, and lowered acetylcholinesterase, PDE5, arginase, ACE and oxidative stress markers, to levels close to untreated controls. Only tissue markers are reported in the abstract.

Side effects and drug interactions

Common Potential side effects

Testicular changes in rats: 28 days at 18 to 100 mg/kg altered testicular markers the authors called adverse.
No human safety data: fadogia has not been tested in people, so its side effects and a safe dose are unknown.
Liver and kidney: 28 days in rats raised serum enzymes and malondialdehyde, which the authors linked to disrupted cell membranes.
Product content varies: in one analysis, the plant's phenolic compounds were not detected in 5 of 17 supplements claiming to contain fadogia.

Important Drug interactions

Testosterone therapy or other hormone treatments: no interaction data; the extract raised testosterone in rats.
Hormone-sensitive conditions: no human data; because rat testosterone rose, ask a clinician before use.
Medicines that can strain the liver or kidneys: no interaction data; 28-day rat dosing raised organ damage markers.

Frequently asked questions about Fadogia Agrestis

Has Fadogia agrestis been tested in people?

No. A PubMed search for fadogia (20 records, October 2026) and a ClinicalTrials.gov search found no human study. Its reputation rests on rat studies, so there is no tested human dose and no shown human benefit or safety record.

Does Fadogia agrestis raise testosterone?

In male rats, 5 days of a stem extract at 18, 50 or 100 mg/kg raised serum testosterone. Whether it changes testosterone in men is unknown because it has not been tested in people. Bulbine natalensis, another herb sold for testosterone, has its own page.

Why do rat studies of Fadogia agrestis raise concerns about the testes?

The same 18 to 100 mg/kg doses that raised testosterone over 5 days, given for 28 days, altered testicular markers in ways the authors called adverse, and also raised liver and kidney damage markers. Recovery after stopping was partial, mainly at the lowest dose.

Do Fadogia agrestis supplements contain what the label says?

Not always, by one measure. A lab analysis of 17 supplements claiming to contain fadogia found the plant's phenolic compounds in 12 (0.3 to 2.7 mg per day) and did not detect them in 5. This test checks chemical identity, not potency or safety.

Has Fadogia agrestis been studied together with tongkat ali?

No. None of the 20 PubMed records on fadogia tested it in combination with tongkat ali, in people or in animals, so any benefit claimed for the pairing is untested.

What is Fadogia Agrestis?

Fadogia agrestis (also classified as Vangueria agrestis) is an African shrub sold in supplements marketed for testosterone. It has not been tested in people. In male rats, 28 days of a stem extract altered testicular markers in ways the authors called adverse and raised serum enzymes and malondialdehyde that the author…

What is Fadogia Agrestis used for?

NutraSmarts does not list Fadogia Agrestis under a health category. What the research covers: In male rats, a water extract of fadogia stem given by mouth at 18, 50 or 100 mg/kg a day raised serum testosterone at every dose over 5 days, in a pattern the authors described as suggestive of dose dependence.

What is the recommended dosage of Fadogia Agrestis?

No human dose has been tested. Rat studies gave 18, 50 or 100 mg/kg a day of a water extract of the stem by mouth for 5 days (raised testosterone) or 28 days (adverse testicular, liver and kidney marker changes). Always follow the product label and check with a healthcare provider for personal advice.

Is Fadogia Agrestis safe, and does it have side effects?

Side effects and cautions reported for Fadogia Agrestis include: Testicular changes in rats: 28 days at 18 to 100 mg/kg altered testicular markers the authors called adverse. No human safety data: fadogia has not been tested in people, so its side effects and a safe dose are unknown. It may also interact with some medications. Fadogia Agrestis is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Fadogia Agrestis interact with any medications?

Possible interactions include: Testosterone therapy or other hormone treatments: no interaction data; the extract raised testosterone in rats. Hormone-sensitive conditions: no human data; because rat testosterone rose, ask a clinician before use. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Fadogia Agrestis?

NutraSmarts rates the evidence for Fadogia Agrestis as Preliminary (1 out of 5). It is backed by 4 study summaries and 8 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(8 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Yakubu MT, Akanji MA, Oladiji AT. Aphrodisiac potentials of the aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male albino rats. Asian J Androl. 2005;7(4):399-404. doi: 10.1111/j.1745-7262.2005.00052.x.PubMedUsed to support: In male albino rats given 18, 50 or 100 mg/kg of a water extract of the stem by mouth, all doses increased mount and intromission frequency, shortened mount and intromission latency, prolonged ejaculatory latency and raised serum testosterone (suggestive of dose dependence) over 5 days. Alkaloids and saponins were detected, anthraquinones and flavonoids weakly. Rats only.
  2. Yakubu MT, Akanji MA, Oladiji AT. Effects of oral administration of aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem on some testicular function indices of male rats. J Ethnopharmacol. 2008;115(2):288-92. doi: 10.1016/j.jep.2007.10.004.PubMedUsed to support: In male rats given the same 18, 50 or 100 mg/kg doses for 28 days, the extract raised testes-to-body weight ratio, testicular cholesterol, sialic acid and glycogen and lowered testicular alkaline phosphatase, glutamate dehydrogenase and protein (acid phosphatase is listed as both raised and lowered), which the authors read as adverse effects on testicular function. Recovery on some indices over 10 days was seen mainly at 18 mg/kg. Rats only.
  3. Yakubu MT, Oladiji AT, Akanji MA. Mode of cellular toxicity of aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male rat liver and kidney. Hum Exp Toxicol. 2009;28(8):469-78. doi: 10.1177/0960327109106973.PubMedUsed to support: In male rats given 18, 50 or 100 mg/kg for 28 days, liver and kidney alkaline phosphatase, lactate dehydrogenase and gamma-glutamyl transferase fell with corresponding rises in serum, and serum malondialdehyde rose in all treated groups, which the authors read as disruption of liver and kidney cell membranes. No deaths, clinical toxicity signs or liver and kidney weight ratio changes. Rats only.
  4. Ogunro OB, Yakubu MT. Fadogia agrestis (Schweinf. Ex Hiern) Stem Extract Restores Selected Biomolecules of Erectile Dysfunction in the Testicular and Penile Tissues of Paroxetine-Treated Wistar Rats. Reprod Sci. 2023;30(2):690-700. doi: 10.1007/s43032-022-01050-6.PubMedUsed to support: In 30 male Wistar rats (groups of 5) given paroxetine to lower mating behavior, the stem extract at 18, 50 or 100 mg/kg raised penile and testicular nitric oxide, cGMP and antioxidant markers and lowered PDE5, arginase and oxidative markers toward control levels. Rats only; the authors say clinical trials are needed.
  5. Sanon S, Ollivier E, Azas N, Mahiou V, Gasquet M, Ouattara CT, Nebie I, Traore AS, Esposito F, Balansard G, Timon-David P, Fumoux F. Ethnobotanical survey and in vitro antiplasmodial activity of plants used in traditional medicine in Burkina Faso. J Ethnopharmacol. 2003;86(2-3):143-7. doi: 10.1016/s0378-8741(02)00381-1.PubMedUsed to support: Fadogia agrestis was one of seven plants from a Burkina Faso ethnobotanical survey screened in the lab; its alkaloid extract inhibited chloroquine-resistant Plasmodium falciparum W2 in culture with an IC50 between 4 and 10 micrograms/mL. Cell culture only, not a human or animal result.
  6. Avula B, Bae JY, Raman V, Fantoukh OI, Wang YH, Osman AG, Wang M, Ali Z, Khan IA. Quantification of Phenolic Compounds from Fadogia agrestis and Dietary Supplements using UHPLC-PDA-MS. Planta Med. 2019;85(2):145-153. doi: 10.1055/a-0715-1801.PubMedUsed to support: Notes traditional African use as an analgesic, anti-inflammatory and aphrodisiac. Of 17 dietary supplements analyzed, 12 contained the plant's phenolic compounds (0.3 to 2.7 mg per day) and in 5 they were not detected. Analytical study; no health outcomes.
  7. Avula B, Bae JY, Wang YH, Wang M, Osman AG, Smith K, Yuk J, Ali Z, Plumb R, Isaac G, Khan IA. Chemical profiling and characterization of phenolic acids, flavonoids, terpene glycosides from Vangueria agrestis using ultra-high-performance liquid chromatography/ion mobility quadrupole time-of-flight mass spectrometry and metabolomics approach. Biomed Chromatogr. 2020;34(9):e4840. doi: 10.1002/bmc.4840.PubMedUsed to support: Describes Vangueria agrestis (GBIF lists Fadogia agrestis as a synonym of this name) as a tropical African shrub used traditionally as a decoction for fever, pain and malaria, and identifies 73 compounds in the plant and in dietary supplements. Two co-authors were from Waters Corporation, the instrument maker. Analytical study; no health outcomes.
  8. Anero R, Díaz-Lanza A, Ollivier E, Baghdikian B, Balansard G, Bernabé M. Monoterpene glycosides isolated from Fadogia agrestis. Phytochemistry. 2008;69(3):805-11. doi: 10.1016/j.phytochem.2007.09.024.PubMedUsed to support: Isolated and identified six monoterpene glycosides from Fadogia agrestis. Chemistry only; no biological or health outcomes.